[1]TetrahedronLetters,2002,vol.43,p.3551-3554
[2]OrganicLetters,2021,vol.23,p.3394-3398
[3]OrganicLetters,2020,vol.22,p.6557-6561
[4]NewJournalofChemistry,2005,vol.29,p.769-772
[5]Synlett,2009,p.818-822
[6]Patent:WO2012/52451,2012,A1.Locationinpatent:Page/Pagecolumn47
[7]ArchivesofPharmacalResearch,2013,vol.36,p.436-447
[8]MonatsheftefurChemie,2016,vol.147,p.1819-1824
[9]SyntheticCommunications,2017,vol.47,p.1013-1019
[10]Patent:WO2013/24149,2013,A1.Locationinpatent:Page/Pagecolumn44
[11]Patent:US2013/210851,2013,A1.Locationinpatent:Paragraph0221-0226
[12]Molecules,2017,vol.22
[13]JournalofHeterocyclicChemistry,2003,vol.40,p.689-695
[14]EuropeanJournalofOrganicChemistry,2002,p.2764-2769
[15]CanadianJournalofChemistry,1980,vol.58,p.2207-2211
[16]JournaloftheChemicalSociety,1906,vol.89,p.200
[17]JournalofOrganicChemistry,1970,vol.35,p.1632-1641
[18]BioorganicandMedicinalChemistry,1999,vol.7,p.2415-2425
[19]Synthesis,2009,p.985-999
[20]GreenChemistry,2013,vol.15,p.1910-1924
[21]AdvancedSynthesisandCatalysis,2013,vol.355,p.2550-2557
[22]Patent:WO2014/2058,2014,A2.Locationinpatent:Page/Pagecolumn75
[23]TetrahedronLetters,2014,vol.55,p.1686-1688
[24]ACSCombinatorialScience,2015,vol.17,p.404-408
[25]ResearchonChemicalIntermediates,2016,vol.42,p.3413-3423
[26]ResearchonChemicalIntermediates,2016,vol.42,p.499-509
[27]TetrahedronLetters,2018,vol.59,p.3069-3076
[28]TetrahedronLetters,2018,vol.59,p.3069-3076
[29]TetrahedronLetters,2018,vol.59,p.3069-3076
[30]TetrahedronLetters,2018,vol.59,p.3069-3076
[31]TetrahedronLetters,2018,vol.59,p.3069-3076
[32]TetrahedronLetters,2018,vol.59,p.3069-3076
[33]TetrahedronLetters,2018,vol.59,p.3069-3076
[34]TetrahedronLetters,2018,vol.59,p.3069-3076
[35]TetrahedronLetters,2018,vol.59,p.3069-3076
[36]TetrahedronLetters,2018,vol.59,p.3069-3076
[37]TetrahedronLetters,2018,vol.59,p.3069-3076
[38]TetrahedronLetters,2018,vol.59,p.3069-3076
[39]TetrahedronLetters,2018,vol.59,p.3069-3076
[40]TetrahedronLetters,2018,vol.59,p.3069-3076
[41]TetrahedronLetters,2018,vol.59,p.3069-3076
[42]TetrahedronLetters,2018,vol.59,p.3069-3076
[43]TetrahedronLetters,2018,vol.59,p.3069-3076
[44]TetrahedronLetters,2018,vol.59,p.3069-3076
[45]TetrahedronLetters,2018,vol.59,p.3069-3076
[46]TetrahedronLetters,2018,vol.59,p.3069-3076
[47]TetrahedronLetters,2018,vol.59,p.3069-3076
[48]TetrahedronLetters,2018,vol.59,p.3069-3076
[49]TetrahedronLetters,2018,vol.59,p.3069-3076
[50]TetrahedronLetters,2018,vol.59,p.3069-3076
[51]TetrahedronLetters,2018,vol.59,p.3069-3076
[52]TetrahedronLetters,2018,vol.59,p.3069-3076
[53]TetrahedronLetters,2018,vol.59,p.3069-3076
[54]TetrahedronLetters,2018,vol.59,p.3069-3076
[55]TetrahedronLetters,2018,vol.59,p.3069-3076
[56]TetrahedronLetters,2018,vol.59,p.3069-3076
[57]TetrahedronLetters,2018,vol.59,p.3069-3076
[58]TetrahedronLetters,2018,vol.59,p.3069-3076
[59]TetrahedronLetters,2018,vol.59,p.3069-3076
[60]TetrahedronLetters,2018,vol.59,p.3069-3076
[61]TetrahedronLetters,2018,vol.59,p.3069-3076
[62]TetrahedronLetters,2018,vol.59,p.3069-3076
[63]TetrahedronLetters,2018,vol.59,p.3069-3076
[64]InternationalJournalofEnvironmentalResearchandPublicHealth,2018,vol.15
[65]Patent:WO2021/249449,2021,A1.Locationinpatent:Page/Pagecolumn110
[66]ResearchonChemicalIntermediates,2022,vol.48,p.1515-1540
[1]Heterocycles,1991,vol.32,p.23-28
[1]Tetrahedron,1995,vol.51,p.12775-12780
[1]Tetrahedron,1998,vol.54,p.935-942
[1]OrganicLetters,2000,vol.2,p.1109-1112
Title: Enaminones 12. An explanation of anticonvulsant activity and toxicity per Linus Pauling's clathrate hypothesis.
Journal: European journal of medicinal chemistry 20120501
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101